Tamarac, FLNCT07659795Now EnrollingIRB Ready

Colorectal Cancer Clinical Trial in Tamarac, FL

Access cutting-edge colorectal cancer treatment through this phase 2 clinical trial at a research site in Tamarac. Study-provided care at no cost to qualified participants.

Sponsored by Verastem, Inc.

Quick Self-Assessment

See if you qualify for this Tamarac location

Preparing your pre-screening questions…

Expert Care in Tamarac

Access colorectal cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related colorectal cancer treatment provided free

Apply for This Tamarac Location

Check if you qualify for this colorectal cancer clinical trial in Tamarac, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tamarac

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tamarac site if eligible
  4. 4Begin participation

About This Colorectal Cancer Study in Tamarac

This study will assess the safety and efficacy of VS-7375 alone and in combination with cetuximab or panitumumab and cetuximab plus mFOLFOX in patients with metastatic KRAS G12D - mutated Colorectal Cancer

Sponsor: Verastem, Inc.

Who Can Participate

Inclusion Criteria

Histopathology confirmed metastatic CRC
Measurable disease per RECIST 1.1
Local testing confirmed KRAS G12D mutation (tissue required for confirmatory central testing)
ECOG PS=0 or 1 2L+ patients:
Must have received at least 1 standard chemotherapy for metastatic colorectal adenocarcinoma
Have documented disease progression during or following their most recent prior line of therapy
Have either stable disease, partial response (PR), or complete response (CR) by RECIST v1.1 as the best overall response (BOR) during at least 1 prior systemic therapy. 1L patients:
Treatment-naïve or received no more than 1 cycle of standard systemic therapy for metastatic disease.

Exclusion Criteria

Have any other documented co-existing common RAS mutation(s)
Prior anti-cancer Tx within 4 weeks or drug-specific timeline within first treatment dose, whichever shorter
Major surgery within 4 weeks of first treatment dose
Radiation therapy (RT) within 1 week of first treatment dose
Receipt of prior direct RAS inhibitor
Receipt of more than 1 investigational therapy
Untreated or symptomatic CNS metastasis
Receipt of strong CYP3A4 inhibitor/inducer or CYP3A4 sensitive substrates with narrow therapeutic index within 14 days or drug-specific timeline within first treatment dose, whichever is shorter
Receipt of PPI or H2 blocker within 5 days
Inability to swallow oral medication
Other protocol-defined inclusion/exclusion criteria may apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tamarac?

Yes, this clinical trial (NCT07659795) has an active research site in Tamarac, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Colorectal Cancer Treatment Options in Tamarac, FL

If you're searching for colorectal cancer treatment options in Tamarac, FL, this clinical trial (NCT07659795) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tamarac research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced colorectal cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all colorectal cancer clinical trials near you to find additional studies recruiting in your area.

More Colorectal Cancer Trials in Tamarac, FL

See all colorectal cancer clinical trials recruiting in Tamarac — not just this study.

Browse Colorectal Cancer Trials in Tamarac →

Browse More Trials by Condition

Colorectal Cancer TrialsAll Conditions →

Ready to Join in Tamarac?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tamarac, FL